

| 货号 | CY257016 | ||||
|---|---|---|---|---|---|
| 品牌 | abinScience | ||||
| 描述 |
Blontuvetmab (CY257016) is a research-grade recombinant antibody targeting CD20. Produced in mammalian cells with native-like glycosylation.
Highlights
| ||||
| 种属反应性 | Canine | ||||
| 应用 | ELISA, Bioactivity: FACS, Functional assay, Research in vivo | ||||
| 宿主 | Canine | ||||
| 同种型 | IgG2-kappa-lambda | ||||
| 表达系统 | Mammalian cells | ||||
| 克隆类型 | Monoclonal | ||||
| 靶标 | CD20/MS4A1 | ||||
| 内毒素水平 | < 10 EU/mg | ||||
| 纯度 | >95% purity as determined by SDS-PAGE. | ||||
| 纯化方式 | Protein A/G purified from cell culture supernatant. | ||||
| Accession号 | Q3C2E2 | ||||
| 状态 | Liquid | ||||
| 保存溶液 | 0.01M PBS pH 7.4 Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA. |
||||
| 产品使用信息 |
| ||||
| 稳定性和存储 | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. | ||||
| 别名 | AT-004, VT-007, 1608112-78-2 | ||||
| 背景 | B-lymphocyte antigen CD20 (MS4A1) is a ~33 kDa protein. B-lymphocyte-specific membrane protein that plays a role in the regulation of cellular calcium influx necessary for the development, differentiation, and activation of B-lymphocytes. Functions as a store-operated calcium (SOC) channel component promoting calcium influx after activation by the B-cell receptor/BCR. CD20 is the therapeutic target of rituximab (MabThera) and obinutuzumab (Gazyva). | ||||
| Note | For research use only. Not suitable for clinical or therapeutic use. |

SDS-PAGE for Research Grade Blontuvetmab.



24小时产品查询

扫一扫关注我们

专属渠道经理